Committed Capital

How did PE investments in life sciences and healthcare fare in 2020, and what do this year and future years have in store for those sectors? In this episode, Dechert's Robert Darwin and senior PE leaders with experience at Blue Ox Healthcare, Mid Europa Partners, TPG and GHO Capital discuss key themes and opportunities affecting private equity investment in life sciences and healthcare and how the market is shaping up in the U.S. and Europe, in 2021 and beyond.

What does it take to get deals done in the current environment? Dechert breaks it down, along with guest speakers from Cerberus Capital Management, First Atlantic Capital, and Blackstone. We discuss what types of deals took place in the early stages of the COVID-19 coronavirus pandemic, what types of deals they are doing now, and how they’re getting the deals done.

Delaware recently reaffirmed its status as a sandbagging state, allowing buyers to bring claims against sellers for breaches of representations and warranties, despite buyers' awareness of these breaches before closing. In this Sidecar episode of Committed Capital, Dechert's Christian Matarese and Daniel Rubin discuss the arguments for and against sandbagging, new guidance from the Delaware Court of Chancery on sandbagging under Delaware law, and market practice on this deal point.

Today's private equity landscape stands in contrast to the anomalous levels of activity in 2021. Rising interest rates, a looming economic downturn and geopolitical tensions have impacted deal activity, yet fundraising and buyouts remain above pre-pandemic levels. How are dealmakers finding creative solutions and opportunities during these uncertain times?
In this special episode of Committed Capital, industry leaders from AllianceBernstein, Eurazeo and Primavera Capital Group offer their perspectives on findings from the 2023 Global Private Equity Outlook report published by Dechert and Mergermarket, including the appetite for buy-and-build strategies, the growth of retailization, continued expansion of private credit financing and GP-led secondaries, ESG and more.

In recent years, the food and agricultural sector has seen growing interest from private equity investment. Driven by an increased demand for food, environmental, social and governance issues, as well as an awareness of climate change, investor interest in sustainable agriculture is set to continue and grow. What are the key drivers behind this trend? In this episode, Dechert’s Nick Marchica leads a discussion with Blue Road Capital’s David Blue and Farmers Gate’s Daniel Fabian on what makes investing in food and agriculture so appealing, how investors can innovate to meet the increasing demand, and the trends and issues likely to shape the sector in years to come.